Efficacy of AAV5-GLA gene therapy in manifest Fabry disease mice

被引：0

作者：

Liefhebber, Jolanda M. P. ^{[1
]}

Brasser, Giso ^{[1
]}

Ferraz, Maria J. ^{[2
]}

Ottenhoff, Roelof ^{[3
]}

Efthymiopoulou, Nikoleta ^{[1
]}

Paerels, Lieke ^{[1
]}

Pereira, Ines ^{[1
]}

Sonea, Andra ^{[1
]}

Allart, Leonie ^{[1
]}

Schwarz, Lukas K. ^{[1
]}

Squeri, Giorgia ^{[1
]}

Dobrynin, Greg ^{[1
]}

Rodriguez, Rosa Crespo ^{[1
]}

Liu, Ying Poi ^{[1
]}

Aerts, Johannes M. F. G. ^{[2
]}

Montenegro-Miranda, Paula S. ^{[1
]}

机构：

[1] UniQure Biopharma BV, Amsterdam, Netherlands

[2] Leiden Univ, Leiden, Netherlands

[3] Univ Amsterdam, Amsterdam UMC, Amsterdam, Netherlands

来源：

MOLECULAR GENETICS AND METABOLISM | 2023年 / 138卷 / 02期

关键词：

D O I：

10.1016/j.ymgme.2022.107206

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

223

引用

页码：81 / 82

页数：2

共 50 条

[1] AAV5-GLA Gene Therapy Results in Sustained Long Term GLA Transgene Expression and Cross Correction of Target Organs in Fabry Disease Mouse Model
Liefhebber, Jolanda M. P.
Brasser, Giso
Revers, Ilma
Paerels, Lieke
Ferraz, Maria J.
Ottenhoff, Roelof
Schwarz, Lukas K.
Squeri, Giorgia
Pereira, Ines L.
Allart, Leonie
Tripathi, Shrijana
Efthymiopoulou, Nikoleta
Dobrynin, Greg
Montenegro-Miranda, Paula S.
de Vries, Carlie J. M.
Aerts, Johannes M. F. G.
Liu, Ying Poi
MOLECULAR THERAPY, 2022, 30 (04) : 472 - 472
[2] Pre-clinical proof of concept of an AAV5-GLA gene therapy for Fabry disease resulting in cross-correction in GLA-KO mice and non-human primates in target organs
Liefhebber, J. M. P.
Brasser, G.
Revers, I.
Paerels, L.
Squeri, G.
Schwarz, K.
Spronck, L.
Oudshoorn-Dickmann, M.
Ferraz, M. J.
Ottenhoff, R.
Pereira, I. L.
Allart, L.
Tripathi, S.
Kuo, C.
Montenegro-Miranda, P.
de Vries, C. J. M.
Aerts, J. M. F. G.
Poi-Liu, Y.
HUMAN GENE THERAPY, 2021, 32 (19-20) : A8 - A9
[3] Development of an AAV5-Based Gene Therapy for Fabry Disease
Liefhebber, Jolanda M. P.
van der Zon, Tom
Paerels, Lieke
Ferraz, Maria J.
Ottenhoff, Roelof
Zancanella, Vanessa
Au, Betty
Kuo, Chi-Lin
de Vries, Carlie J. M.
Evers, Melvin M.
Konstantinova, Pavlina
Aerts, Johannes M. F. G.
Van Deventer, Sander J.
Liu, Ying Poi
MOLECULAR THERAPY, 2019, 27 (04) : 442 - 443
[4] Development of an AAV5-based gene therapy for Fabry disease
Liu, Ying Poi
Liefhebber, Jolanda M. P.
van der Zon, Tom
Paerels, Lieke
Ferraz, Maria J.
Ottenhoff, Roelof
Zancanella, Vanessa
Au, Betty
Kuo, Chi-Lin
de Vries, Carlie J. M.
Evers, Melvin M.
Konstantinova, Pavlina
Aerts, Johannes M. F. G.
Van Deventer, Sander J.
MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S99 - S99
[5] Age-related efficacy with an AAV vector in Fabry disease mice
Koeberl, Dwight D.
MOLECULAR GENETICS AND METABOLISM, 2009, 96 (03) : 83 - 84
[6] AAV1 mediated gene therapy of neonatal Fabry mice
Ogawa, Koichi
Hirai, Yukihiko
Zenri, Katsuko
Fukunaga, Yoshitaka
Shimada, Takashi
JOURNAL OF GENE MEDICINE, 2006, 8 (12): : 1461 - 1461
[7] GLA Uptake and Metabolic Cross Correction in Fabry Disease Relevant Cell Lines: A Rationale for Liver-Directed AAV Gene Therapy
Jeyakumar, Jey
Tam, Lawrence
Kia, Azadeh
Sheridan, Rose
Nathwani, Amit
Corbau, Romuald
MOLECULAR THERAPY, 2021, 29 (04) : 248 - 248
[8] PREIMPLANTATION GENETIC DIAGNOSIS OF FABRY DISEASE (GLA GENE)
Hejtmankova, M.
Hlavova, E.
Putzova, M.
Eliasova, I
Mika, J.
Brandejska, M.
Stejskal, D.
Louzecka, A.
Vlaskova, H.
Kozich, V
JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S188 - S188
[9] Comprehensive study of Fabry disease: Gene mutation, GLA activity, GLA protein and globotriaosylsphingosine
Tsukimura, Takahiro
Togawa, Tadayasu
Sakuraba, Hitoshi
MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S117 - S117
[10] rAAV Gene Therapy for Fabry Disease: Enhanced Secretion of a-GLA by Signal Peptide Engineering
Dong, Biao
MOLECULAR THERAPY, 2023, 31 (04) : 491 - 491

← 1 2 3 4 5 →